Ralph G Zinner Selected Research

Ralph G Zinner Research Topics

Disease

27	Neoplasms (Cancer) 01/2021 - 01/2003
20	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2018 - 07/2002
4	Thrombocytopenia (Thrombopenia) 01/2019 - 02/2014
3	Ovarian Neoplasms (Ovarian Cancer) 01/2021 - 01/2014
3	Fatigue 11/2016 - 08/2007
3	Neutropenia 10/2016 - 04/2010
2	Melanoma (Melanoma, Malignant) 01/2021 - 01/2019
2	Anemia 10/2016 - 01/2015
2	Diarrhea 10/2016 - 03/2006
2	Mesothelioma 07/2004 - 04/2004
2	Prostatic Neoplasms (Prostate Cancer) 07/2003 - 01/2003
1	Adenocarcinoma of Lung 01/2021
1	Hypertension (High Blood Pressure) 01/2021
1	Exanthema (Rash) 01/2021
1	Chronic Disease (Chronic Diseases) 11/2018
1	Hyperglycemia 10/2016
1	Mucositis 10/2016
1	Squamous Cell Carcinoma of Head and Neck 04/2016
1	Histiocytic Sarcoma 01/2016
1	Triple Negative Breast Neoplasms 12/2014
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 10/2013
1	Neoplasm Metastasis (Metastasis) 01/2011
1	Thromboembolism 01/2011
1	Fever (Fevers) 04/2010
1	Esophagitis 01/2009
1	Dehydration (Water Stress) 08/2007
1	Vomiting 08/2007
1	Nausea 08/2007
1	Agranulocytosis (Granulocytopenia) 08/2007
1	Lung Neoplasms (Lung Cancer) 08/2007
1	Disease Progression 01/2003
1	Breast Neoplasms (Breast Cancer) 07/2002

Drug/Important Bio-Agent (IBA)

9	Pemetrexed (MTA)FDA Link 11/2018 - 04/2004
8	Carboplatin (JM8)FDA LinkGeneric 01/2019 - 12/2005
4	Paclitaxel (Taxol)FDA LinkGeneric 01/2019 - 09/2010
4	Bevacizumab (Avastin)FDA Link 04/2016 - 02/2010
4	Cisplatin (Platino)FDA LinkGeneric 08/2007 - 04/2004
3	Pharmaceutical PreparationsIBA 05/2017 - 01/2015
3	Formaldehyde (Formol)FDA Link 01/2016 - 08/2014
3	ParaffinIBA 01/2016 - 08/2014
3	Gemcitabine FDA Link 04/2010 - 04/2004
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2021 - 01/2019
2	VemurafenibIBA 01/2021 - 01/2019
2	PlatinumIBA 11/2018 - 03/2010
2	Cetuximab (Erbitux)FDA Link 04/2016 - 10/2013
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2016 - 12/2014
2	DNA (Deoxyribonucleic Acid)IBA 09/2015 - 05/2015
2	Biomarkers (Surrogate Marker)IBA 08/2014 - 05/2007
2	Drug CombinationsIBA 02/2014 - 03/2009
2	Erlotinib Hydrochloride (CP 358,774)FDA Link 10/2013 - 06/2011
2	Hemoglobins (Hemoglobin)IBA 01/2011 - 03/2006
2	Docetaxel (Taxotere)FDA Link 04/2010 - 08/2007
2	Canertinib (CI 1033)IBA 05/2007 - 05/2005
2	AntimetabolitesIBA 07/2004 - 04/2004
2	Trastuzumab (Herceptin)FDA Link 04/2004 - 07/2002
1	Sorafenib (BAY 43-9006)FDA Link 01/2021
1	CrizotinibIBA 01/2021
1	CreatinineIBA 01/2019
1	Histone Deacetylase InhibitorsIBA 10/2016
1	Sirolimus (Rapamycin)FDA Link 10/2016
1	Vorinostat FDA Link 10/2016
1	temsirolimus FDA Link 04/2016
1	Cell-Free Nucleic AcidsIBA 01/2016
1	Biological ProductsIBA 05/2015
1	1- (3- C- ethynylribopentofuranosyl)cytosineIBA 02/2014
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 02/2014
1	NucleotidesIBA 01/2014
1	Taxoids (Taxanes)IBA 04/2010
1	Vinorelbine (Navelbine)FDA LinkGeneric 04/2010
1	Filgrastim (Neupogen)FDA Link 04/2010
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 03/2010
1	AntioxidantsIBA 08/2007
1	Antineoplastic Agents (Antineoplastics)IBA 08/2007
1	motexafin gadoliniumIBA 08/2007
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 05/2007
1	ErbB Receptors (EGF Receptor)IBA 05/2007
1	Gefitinib (Iressa)FDA Link 03/2006
1	Amifostine (Ethyol)FDA LinkGeneric 04/2004
1	Liposomes (Liposome)IBA 07/2003
1	Peptides (Polypeptides)IBA 01/2003
1	AntibodiesIBA 01/2003
1	Monoclonal AntibodiesIBA 07/2002

Therapy/Procedure

12	Therapeutics 11/2018 - 05/2005
4	Drug Therapy (Chemotherapy) 01/2017 - 04/2004
3	Radiotherapy 01/2009 - 04/2004
2	Combination Drug Therapy (Combination Chemotherapy) 12/2014 - 04/2010
1	Maintenance Chemotherapy 11/2018
1	Continuity of Patient Care 11/2018
1	Salvage Therapy 04/2010
1	Chemoradiotherapy 04/2004